Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

JUXTAPID vs KETOPROFEN LYSINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

JUXTAPID vs KETOPROFEN LYSINE: Safety Overview

Metric JUXTAPID KETOPROFEN LYSINE
Total FAERS Reports 179 380
Deaths Reported 2 1
Death Rate 1.1% 0.3%
Hospitalizations 13 177
Average Patient Age 58.0 yrs 40.8 yrs
% Female Patients N/A 55.3%